Dr. Elizabeth Conner Discusses DCP as a Biomarker for Hepatocellular Carcinoma at ASCO GI 2024

At the 2024 American Society of Clinical Oncology Gastrointestinal Cancers Symposium, Dr. Elizabeth Conner from the University of California, San Diego, offered insight on how des-gamma-carboxy prothrombin can be utilized as a biomarker for treatment response in patients with HCC receiving first-line treatment of atezolizumab/bevacizumab.
Catch up on more ASCO #GI24 coverage here: https://www.docwirenews.com/conference/asco-gi-symposium-2024

Видео Dr. Elizabeth Conner Discusses DCP as a Biomarker for Hepatocellular Carcinoma at ASCO GI 2024 канала GI Oncology Now